Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors

Zoledronic acid-encapsulating self-assembling nanoparticles and doxorubicin: a combinatorial approach to overcome simultaneously chemoresistance and immunoresistance in breast tumors

The resistance to chemotherapy and the tumor escape from host immunosurveillance are the main causes of the failure of anthracycline-based regimens in breast cancer, where an effective chemo-immunosensitizing strategy is lacking.

Bibliographic Details
Main Authors: Kopecka, Joanna, Porto, Stefania, Lusa, Sara, Gazzano, Elena, Salzano, Giuseppina, Pinzòn-Daza, Martha Leonor, Giordano, Antonio, Desiderio, Vincenzo, Ghigo, Dario, De Rosa, Giuseppe, Caraglia, Michele, Riganti, Chiara
Format: Online
Language:English
Published: Impact Journals LLC 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991490/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991490/

Similar Items